Invest
1 investments found
Synartro
Synartro develops improved treatments based on patented drug delivery technology and novel
uses of drugs with proven safety and efficacy.
Funded
SEK 21,270,530
Capital Target
SEK 60,000,000
Max. Raise
SEK 60,012,950
Min. Raise
SEK 30,000,000
Percent of Equity Offered
54%
Valuation of equity
SEK 52000000
End Date
10 June 2021